Milestone Pharmaceuticals (MIST) Receivables - Net (2026)

Milestone Pharmaceuticals' (MIST) quarterly Receivables - Net came in at $1.6 million in Q1 2026.

Milestone Pharmaceuticals (MIST) Receivables - Net (2026) Analysis & Trends

Milestone Pharmaceuticals (MIST) has 1 years of Receivables - Net data on file, last reported at $1.6 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.57 Bn	130.72 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.99 Bn	77.99 Bn	3.93 Bn
3	Argenx Se	65.00 Bn	59.82 Bn	1.37 Bn
4	Moderna	56.27 Bn	51.13 Bn	52.00 Mn
5	BeOne Medicines	42.00 Bn	36.90 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.60 Bn	28.29 Bn	992.69 Mn
7	BioNTech SE	27.68 Bn	9.29 Bn	668.28 Mn
8	Insmed	27.43 Bn	26.27 Bn	358.27 Mn
9	Royalty Pharma	27.34 Bn	26.51 Bn	-
10	Milestone Pharmaceuticals	42.91 Mn	-128.59 Mn	-

Download Data